Market Report, "Sweden Pharmaceuticals & Healthcare Report Q1 2015", published

From: Fast Market Research, Inc.
Published: Fri Nov 28 2014

Declining government reimbursement for prescription medicines does not bode well for innovative drugmakers selling their products in Sweden, particularly as the government is the primary purchaser of pharmaceuticals. Furthermore, over the long term, pushing costs onto a population with fewer young people to financially support the elderly will ultimately work to reduce the consumption of higher-value innovative pharmaceuticals.

Headline Expenditure Projections

* Pharmaceuticals: SEK36.28bn (USD5.70bn) in 2013 to SEK36.41bn (USD5.36bn) in 2014; +0.38% in local currency terms and -5.9% in US dollar terms.
* Healthcare: SEK351.16bn (USD55.18bn) in 2013 to SEK356.95bn (USD52.56bn) in 2014; +1.6% in local currency terms and -4.7% in US dollar terms.

Risk/Reward Index: We continue to view Sweden as a moderately attractive regional market. On the positive side, factors such as the country's high per capita incomes and strong regulatory foundations will continue to promote per capita spending on pharmaceuticals and healthcare in general. However, the downward pressure on pharmaceutical prices will continue to be acutely felt in this small market of fewer than 10mn people.

Full Report Details at

Key Trends And Developments

Sweden has the best healthcare system to deal with diabetes of all the EU member states, including Norway and Switzerland, as it has a better national registry, according to the 2014 Euro Diabetes Index launched in Vienna. Sweden was followed by the Netherlands, Denmark and the UK, while Bulgaria, Lithuania and Estonia scored lowest. The analysis, which came from the Health Consumer Powerhouse (HCP), was based on 28 defined indicators and areas, including prevention, case finding, range and reach of services, access to treatment and care, procedures and outcomes. Sweden only needs to improve its prevention under 'Exercise in compulsory school', according to the HCP.

About 850,000 false prescriptions are corrected by pharmacies every year in Sweden,...

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Slovenia Pharmaceuticals & Healthcare Report Q1 2015
- Thailand Pharmaceuticals & Healthcare Report Q1 2015
- Kenya Pharmaceuticals & Healthcare Report Q1 2015
- Hong Kong Pharmaceuticals & Healthcare Report Q1 2015
- Croatia Pharmaceuticals & Healthcare Report Q1 2015

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »